Home
News
Create
Screeners
Insights
Aarti Pharma Labs
778.
70
+14.00
(+1.83%)
Market Cap
₹7,058.70 Cr
PE Ratio
28.99
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.83%
1M
+5.17%
6M
-16.02%
1Y
+17.97%
5Y
+170.15%
View Company Insights
Latest news about Aarti Pharma Labs
Aarti Pharmalabs Limited Appoints Dr. Rakeshwar Bandichhor as Chief Scientific Officer - R&D
Jan 01, 2026
Aarti Pharmalabs Limited has appointed Dr. Rakeshwar Bandichhor as Chief Scientific Officer - R&D effective January 01, 2026, following Board approval based on Nomination and Remuneration Committee recommendation. Dr. Bandichhor brings 25 years of experience in API-R&D and Process Chemistry, with strong academic credentials including M.Sc. degrees and Ph.D. in Chemistry, plus postdoctoral training from universities in Germany and USA. He was previously associated with Dr. Reddy's Laboratories in Hyderabad.
Aarti Pharmalabs Reports 11% Revenue Growth in Q2FY26, Revises EBITDA Growth Guidance
Nov 17, 2025
Aarti Pharmalabs Reports Strong Q2 Performance with 11% Revenue Growth
Nov 09, 2025
Aarti Pharma Labs Bolsters Leadership with Two Key Senior Management Appointments
Nov 09, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation